Profiling of metastases in resectable lung cancer reveals a key role for miRNA-PD-L1 axis in the resistance to neoadjuvant chemotherapy

MLA

Cuttano, R., et al. Profiling of Metastases in Resectable Lung Cancer Reveals a Key Role for MiRNA-PD-L1 Axis in the Resistance to Neoadjuvant Chemotherapy. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1440494001&authtype=sso&custid=ns315887.

APA

Cuttano, R., Colangelo, T., Afanga Kuku, M., Dama, E., Mazzarelli, F., Melocchi, V., & Bianchi, F. (2022). Profiling of metastases in resectable lung cancer reveals a key role for miRNA-PD-L1 axis in the resistance to neoadjuvant chemotherapy.

Chicago

Cuttano, R, T Colangelo, M Afanga Kuku, E Dama, F Mazzarelli, V Melocchi, and F Bianchi. 2022. “Profiling of Metastases in Resectable Lung Cancer Reveals a Key Role for MiRNA-PD-L1 Axis in the Resistance to Neoadjuvant Chemotherapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1440494001&authtype=sso&custid=ns315887.